iTeos Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 3.80 M | $29.20 M | -2.09% | 8.81% |
| MPM ASSET MANAGEMENT LLC | 02/14/2025 | 2.74 M | $21.03 M | 0.00% | 6.35% |
| BVF INC/IL | 02/14/2025 | 2.33 M | $17.86 M | 100.00% | 5.39% |
| RA CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 2.09 M | $16.07 M | -34.30% | 4.85% |
| JPMORGAN CHASE & CO | 02/12/2025 | 2.07 M | $15.89 M | 342.69% | 4.80% |
| BIOIMPACT CAPITAL LLC | 02/14/2025 | 1.75 M | $13.41 M | 0.00% | 4.05% |
| VANGUARD GROUP INC | 02/11/2025 | 1.63 M | $12.55 M | -1.38% | 3.79% |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 1.21 M | $9.29 M | 15.66% | 2.81% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 1.07 M | $8.24 M | 4,797.72% | 2.49% |
| 02/14/2025 | 946,915 | $7.27 M | 100.00% | 2.20% | |
| 683 CAPITAL MANAGEMENT, LLC | 02/14/2025 | 918,117 | $7.05 M | -41.53% | 2.13% |
| VESTAL POINT CAPITAL, LP | 02/14/2025 | 900,000 | $6.91 M | -12.20% | 2.09% |
| CITIGROUP INC | 02/12/2025 | 853,781 | $6.56 M | 4,128.31% | 1.98% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 837,200 | $6.43 M | 56.08% | 1.94% |
| CAPTION MANAGEMENT, LLC | 02/14/2025 | 760,500 | $5.84 M | 280.25% | 1.76% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 730,491 | $5.61 M | -19.99% | 1.69% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 644,901 | $4.95 M | 0.71% | 1.50% |
| STATE STREET CORP | 02/14/2025 | 585,936 | $4.50 M | -50.15% | 1.36% |
| CAPTION MANAGEMENT, LLC | 02/14/2025 | 509,829 | $3.92 M | 100.00% | 1.18% |
| ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 470,146 | $3.61 M | 2,681.76% | 1.09% |
| JANE STREET GROUP, LLC | 02/14/2025 | 423,200 | $3.25 M | 100.00% | 0.98% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 411,072 | $3.16 M | 1,008.82% | 0.95% |
| ALMITAS CAPITAL LLC | 02/14/2025 | 275,120 | $2.11 M | 100.00% | 0.64% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 233,876 | $1.80 M | 1,096.91% | 0.54% |
| PRUDENTIAL FINANCIAL INC | 02/11/2025 | 232,091 | $1.78 M | -8.37% | 0.54% |
| TANG CAPITAL MANAGEMENT LLC | 02/14/2025 | 221,716 | $1.70 M | -90.79% | 0.51% |
| EVERSEPT PARTNERS, LP | 02/14/2025 | 220,196 | $1.69 M | 100.00% | 0.51% |
| AMERIPRISE FINANCIAL INC | 02/14/2025 | 205,188 | $1.58 M | 233.55% | 0.48% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 199,196 | $1.53 M | -10.33% | 0.46% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 194,953 | $1.50 M | 11.03% | 0.45% |
| DAFNA CAPITAL MANAGEMENT LLC | 02/14/2025 | 188,347 | $1.45 M | 16.56% | 0.44% |
| K2 PRINCIPAL FUND, L.P. | 02/14/2025 | 184,500 | $1.42 M | -54.30% | 0.43% |
| TREXQUANT INVESTMENT LP | 02/12/2025 | 179,966 | $1.38 M | 267.23% | 0.42% |
| JANE STREET GROUP, LLC | 02/14/2025 | 162,500 | $1.25 M | -85.25% | 0.38% |
| RAYMOND JAMES FINANCIAL INC | 02/13/2025 | 150,967 | $1.16 M | 100.00% | 0.35% |
| KENNEDY CAPITAL MANAGEMENT LLC | 02/13/2025 | 138,591 | $1.06 M | -10.84% | 0.32% |
| JANE STREET GROUP, LLC | 02/14/2025 | 135,031 | $1.04 M | 616.46% | 0.31% |
| BARCLAYS PLC | 02/13/2025 | 132,894 | $1.02 M | 17.39% | 0.31% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 02/13/2025 | 131,599 | $1.01 M | -65.07% | 0.31% |
| GROUP ONE TRADING, L.P. | 02/14/2025 | 130,592 | $1.00 M | 100.00% | 0.30% |
| UBS OCONNOR LLC | 02/14/2025 | 125,589 | $964,524 | 90.46% | 0.29% |
| AQR CAPITAL MANAGEMENT LLC | 02/14/2025 | 119,950 | $921,216 | 356.94% | 0.28% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 110,332 | $847,350 | 4.31% | 0.26% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 02/14/2025 | 110,000 | $844,800 | 266.67% | 0.26% |
| 01/29/2025 | 108,853 | $835,991 | 100.00% | 0.25% | |
| VICTORY CAPITAL MANAGEMENT INC | 02/06/2025 | 101,759 | $781,509 | 6.84% | 0.24% |
| VERITION FUND MANAGEMENT LLC | 02/14/2025 | 98,699 | $758,008 | 268.31% | 0.23% |
| UBS GROUP AG | 02/14/2025 | 93,161 | $715,476 | 112.87% | 0.22% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 02/12/2025 | 88,187 | $677,000 | 100.00% | 0.20% |
| INVESCO LTD. | 02/13/2025 | 84,440 | $648,499 | 0.10% | 0.20% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
iTeos Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 182 institutional investors and hedge funds held shares of iTeos Therapeutics, Inc.. The most heavily invested institutionals were:
BlackRock Funding, Inc. /DE: 3.8 M
MPM ASSET MANAGEMENT LLC: 2.74 M
BVF INC/IL: 2.33 M
RA CAPITAL MANAGEMENT, L.P.: 2.09 M
JPMORGAN CHASE & CO: 2.07 M
BioImpact Capital LLC: 1.75 M
79.13% of iTeos Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 39.65 M shares in the last 24 months. This purchase volume represents approximately $319.56 M in transactions.